Financials
- Market Capitalization 322.97 M
- Employee 854
- Founded N/A
- CEO Gary S. Gillheeney Sr.
- Website www.organogenesis.com
- Headquarter Delaware, United States
- FIGI BBG00FGGD295
- Industry Drug Manufacturers—Specialty & Generic
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3118 | EOLS Evolus, Inc. - Common Stock | 5.94 USD | -5.26% | -16.46% | -12.00% | -36.06% | 391.18 M USD | ||
| 3156 | AKBA Akebia Therapeutics, Inc. - Common Stock | 1.38 USD | -1.43% | -1.43% | +50.00% | +16.95% | 370.20 M USD | ||
| 3392 | TKNO Alpha Teknova, Inc. - Common Stock | 5.28 USD | -2.40% | -2.04% | +28.47% | +20.00% | 283.08 M USD | ||
| 3478 | SIGA SIGA Technologies Inc. - Common Stock | 3.48 USD | +1.75% | -3.87% | -19.63% | -59.06% | 249.60 M USD |
Frequently asked questions about Organogenesis Holdings Inc. - Class A
What is the Organogenesis Holdings Inc. - Class A stock price today?
The current price of Organogenesis Holdings Inc. - Class A (ORGO) is 2.51. Over the past 24 hours, the stock has changed by +7.26%. Follow the ORGO chart for real-time price dynamics.
What is the stock ticker of Organogenesis Holdings Inc. - Class A?
Organogenesis Holdings Inc. - Class A trades under the ticker ORGO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Organogenesis Holdings Inc. - Class A stock going up?
ORGO has changed by 0.00% over the last week, +3.72% over the last month, and -41.49% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Organogenesis Holdings Inc. - Class A net income for the last quarter?
Organogenesis Holdings Inc. - Class A reported net income of -53.16 M for the last quarter. The previous quarter showed 43.7 M, which means net income changed by -221.64%.
How many employees does Organogenesis Holdings Inc. - Class A have?
As of the latest available data, Organogenesis Holdings Inc. - Class A has 854 employees. Workforce size can provide additional context about the company's scale and operations.
What is Organogenesis Holdings Inc. - Class A EBITDA?
Organogenesis Holdings Inc. - Class A EBITDA is -60.76 M, and its EBITDA margin is -163.21%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Organogenesis Holdings Inc. - Class A stock?
You can buy Organogenesis Holdings Inc. - Class A (ORGO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Organogenesis Holdings Inc. - Class A stock?
Investing in Organogenesis Holdings Inc. - Class A requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ORGO chart and related analysis on metatrader.com as part of your research.